NCT06604572

Brief Summary

The objective of this study was to explore the clinical efficacy of transabdominal preperitoneal approach (TAPP) and open tension-free hernia repair in the treatment of recurrent inguinal hernia. This study aims to provide a basis for selecting the optimal treatment methods for recurrent hernias.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2022

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

September 15, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
12 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 28, 2025

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

2.4 years

First QC Date

September 15, 2024

Last Update Submit

September 18, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperation pain

    Postoperative pain was monitored using the VAS pain scoring system (0-10 points) and recorded at 24 and 48 h. Patients with groin pain for more than 3 months were recorded during follow-up.

    24 hours, 48 hours, three months after surgery

Secondary Outcomes (8)

  • Numbness and foreign body sensation

    The mean follow-up time was 10 months after surgery

  • Operating time

    During surgery

  • Hemorrhage

    During surgery

  • Urinary retention

    One week after surgery

  • Seroma

    The mean follow-up time was 2 weeks after surgery

  • +3 more secondary outcomes

Study Arms (2)

Transabdominal preperitoneal approach surgery group

EXPERIMENTAL

The enrolled patients were treated with Transabdominal preperitoneal approach

Procedure: Transabdominal preperitoneal approach

Open tension-free hernia repair group

OTHER

The enrolled patients were treated with open tension-free hernia repair

Procedure: Transabdominal preperitoneal approach

Interventions

The enrolled patients underwent either open tension-free hernia repair or Transabdominal preperitoneal approach

Also known as: Open tension-free hernia repair
Open tension-free hernia repair groupTransabdominal preperitoneal approach surgery group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age ≥ 18 years
  • the diagnosis of recurrent inguinal hernia made by ultrasound or computed tomography (CT) during the present visit
  • ability to tolerate general anesthesia and local anesthesia surgery
  • all patients and their families agreed to participate in this study and sign relevant informed consent.

You may not qualify if:

  • patch infection during the first surgery
  • multiple (≥ 2) relapses
  • inability to cooperate to complete follow-up after surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical study of recurrent inguinal hernia

Kunming, Yunnan, 650000, China

RECRUITING

MeSH Terms

Conditions

Hernia, Inguinal

Condition Hierarchy (Ancestors)

Hernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Weiming Li, doctor

    The Second Affiliated Hospital of Kunming Medical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
director

Study Record Dates

First Submitted

September 15, 2024

First Posted

September 19, 2024

Study Start

May 1, 2022

Primary Completion

October 1, 2024

Study Completion

October 28, 2025

Last Updated

September 19, 2024

Record last verified: 2024-09

Locations